Adherence to hypertension and dyslipidemia treatment and its implication on control of cardiovascular disease in Vietnam: A semi-systematic review.

Background: To understand the prevalent issues and challenges in the provision of care for dyslipidemia and hypertension in Vietnamese adults, quantification of patient journey stages (awareness, screening, diagnosis, treatment, adherence, and control) was performed in this semi-systematic review.
Methods: The EMBASE and MEDLINE databases were searched for English articles published between 2010 and 2019. Thesis abstracts, letters to the editor, editorials, case studies, and studies on patient subgroups or nationally unrepresentative studies, were excluded. Articles from Google, the Incidence and Prevalence Database, the World Health Organization, Vietnam's Ministry of Health, and those suggested by the authors were also included. The last search was run on December 10, 2019 for dyslipidemia and hypertension.
Results: A reviewer independently screened 586 retrievals for dyslipidemia and 177 retrievals for hypertension, and extracted data from 2 articles on dyslipidemia and 6 articles on hypertension that were included in the final synthesis.
Conclusion: The data generated in this review will help overcome these issues and barriers to patient care in populations with these 2 conditions.
Competing Interests: Dr. Hieu B Tran has received honoraria from Astra Zeneca, Pfizer, Novartis, Servier, Boehringer Ingelheim, and Sanofi. Dr. Duc Q Dang has received honoraria from the company Pfizer, Servier, and Boehringer. Dr. Sy V Hoang has received honoraria from Astra Zeneca, Pfizer, Merk, Terumo, Boston Scientific, Novartis, Servier, Abbott Vascular, Boeringer Ingelheim, Bayer, Sanofi, and is on the speaker’s bureau for the University of Medicine and Pharmacy at HCM City, and the CME organizer for Cho Ray Hospital, University of Medicine and Pharmacy at HCM City. Dr. Tuan A Vuong has received honoraria from companies Servier, Novartis, and Boehringer. Dr. Hung M Pham has received honoraria from Astra Zeneca, Pfizer, Merk, Terumo, Boston Scientific, Kaneka, Novartis, Biosensor, Servier, Abbott Vascular, AGA, Boeringer Ingelheim, Bayer, Sanofi, and is on the speaker’s bureau for Hanoi Medical University, and the CME organizer for Bach Mai Hospital, Hanoi Medical University. Dr. Grace E Brizuela and Dr. Anh T Q Tran are employees of Viatris. Dr. Thanh H Vu declares no conflict of interest.
(Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.)